Longitudinal analyses of the innate immune system, including the earliest time points, are essential to understand the immunopathogenesis and clinical course of coronavirus disease (COVID-19). Here, we performed a detailed characterization of natural killer (NK) cells in 205 patients (403 samples; days 2 to 41 after symptom onset) from four independent cohorts using single-cell transcriptomics and proteomics together with functional studies. We found elevated interferon (IFN)-α plasma levels in early severe COVD-19 alongside increased NK cell expression of IFN-stimulated genes (ISGs) and genes involved in IFN-α signaling, while upregulation of tumor necrosis factor (TNF)-induced genes was observed in moderate diseases. NK cells exert anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) activity but are functionally impaired in severe COVID-19. Further, NK cell dysfunction may be relevant for the development of fibrotic lung disease in severe COVID-19, as NK cells exhibited impaired anti-fibrotic activity. Our study indicates preferential IFN-α and TNF responses in severe and moderate COVID-19, respectively, and associates a prolonged IFN-α-induced NK cell response with poorer disease outcome.

Original languageEnglish
Pages (from-to)2650-2669.e14
Issue number11
StatePublished - 9 Nov 2021


  • COVID-19
  • NK cells
  • TNF
  • antiviral
  • lung fibrosis
  • moderate
  • proteomics
  • scRNA-seq
  • severe
  • type 1 IFN


Dive into the research topics of 'Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19'. Together they form a unique fingerprint.

Cite this